Cargando…

Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis

BACKGROUND: Conventional phantom-based planar dosimetry (2D-PBD) quality assurance (QA) using gamma pass rate (GP (%)) is inadequate to reflect clinically relevant dose error in intensity-modulated radiation therapy (IMRT), owing to a lack of information regarding patient anatomy and volumetric dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wen-zhao, Zhang, Dan-dan, Peng, Ying-lin, Chen, li, Kang, De-hua, Wang, Bin, Deng, Xiao-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856312/
https://www.ncbi.nlm.nih.gov/pubmed/29544512
http://dx.doi.org/10.1186/s13014-018-0993-2
_version_ 1783307284195049472
author Sun, Wen-zhao
Zhang, Dan-dan
Peng, Ying-lin
Chen, li
Kang, De-hua
Wang, Bin
Deng, Xiao-wu
author_facet Sun, Wen-zhao
Zhang, Dan-dan
Peng, Ying-lin
Chen, li
Kang, De-hua
Wang, Bin
Deng, Xiao-wu
author_sort Sun, Wen-zhao
collection PubMed
description BACKGROUND: Conventional phantom-based planar dosimetry (2D-PBD) quality assurance (QA) using gamma pass rate (GP (%)) is inadequate to reflect clinically relevant dose error in intensity-modulated radiation therapy (IMRT), owing to a lack of information regarding patient anatomy and volumetric dose distribution. This study aimed to evaluate the dose distribution accuracy of IMRT delivery for nasopharyngeal carcinoma (NPC), which passed the 2D-PBD verification, using a measurement-guided 3D dose reconstruction (3D-MGR) method. METHODS: Radiation treatment plans of 30 NPC cases and their pre-treatment 2D-PBD data were analyzed. 3D dose distribution was reconstructed on patient computed tomography (CT) images using the 3DVH software and compared to the treatment plans. Global and organ-specific dose GP (%), and dose-volume histogram (DVH) deviation of each structure was evaluated. Interdependency between GP (%) and the deviation of the volumetric dose was studied through correlation analysis. RESULTS: The 3D-MGR achieved global GP (%) similar to conventional 2D-PBD in the same criteria. However, structure-specific GP (%) significantly decreased under stricter criteria, including the planning target volume (PTV). The average deviation of all inspected dose volumes (D(V)) and volumetric dose (V(D)) parameters ranged from − 2.93% to 1.17%, with the largest negative deviation in V100% of the PTVnx of − 15.66% and positive deviation in D1cc of the spinal cord of 6.66%. There was no significant correlation between global GP (%) of 2D-PBD or 3D-MGR and the deviation of the most volumetric dosimetry parameters (D(V) or V(D)), when the Pearson’s coefficient value of 0.8 was used for correlation evaluation. CONCLUSION: Even upon passing the pre-treatment phantom based dosimetric QA, there could still be risk of dose error like under-dose in PTVnx and overdose in critical structures. Measurement-guided 3D volumetric dosimetry QA is recommended as the more clinically efficient verification for the complicated NPC IMRT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13014-018-0993-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5856312
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58563122018-03-22 Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis Sun, Wen-zhao Zhang, Dan-dan Peng, Ying-lin Chen, li Kang, De-hua Wang, Bin Deng, Xiao-wu Radiat Oncol Research BACKGROUND: Conventional phantom-based planar dosimetry (2D-PBD) quality assurance (QA) using gamma pass rate (GP (%)) is inadequate to reflect clinically relevant dose error in intensity-modulated radiation therapy (IMRT), owing to a lack of information regarding patient anatomy and volumetric dose distribution. This study aimed to evaluate the dose distribution accuracy of IMRT delivery for nasopharyngeal carcinoma (NPC), which passed the 2D-PBD verification, using a measurement-guided 3D dose reconstruction (3D-MGR) method. METHODS: Radiation treatment plans of 30 NPC cases and their pre-treatment 2D-PBD data were analyzed. 3D dose distribution was reconstructed on patient computed tomography (CT) images using the 3DVH software and compared to the treatment plans. Global and organ-specific dose GP (%), and dose-volume histogram (DVH) deviation of each structure was evaluated. Interdependency between GP (%) and the deviation of the volumetric dose was studied through correlation analysis. RESULTS: The 3D-MGR achieved global GP (%) similar to conventional 2D-PBD in the same criteria. However, structure-specific GP (%) significantly decreased under stricter criteria, including the planning target volume (PTV). The average deviation of all inspected dose volumes (D(V)) and volumetric dose (V(D)) parameters ranged from − 2.93% to 1.17%, with the largest negative deviation in V100% of the PTVnx of − 15.66% and positive deviation in D1cc of the spinal cord of 6.66%. There was no significant correlation between global GP (%) of 2D-PBD or 3D-MGR and the deviation of the most volumetric dosimetry parameters (D(V) or V(D)), when the Pearson’s coefficient value of 0.8 was used for correlation evaluation. CONCLUSION: Even upon passing the pre-treatment phantom based dosimetric QA, there could still be risk of dose error like under-dose in PTVnx and overdose in critical structures. Measurement-guided 3D volumetric dosimetry QA is recommended as the more clinically efficient verification for the complicated NPC IMRT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13014-018-0993-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-15 /pmc/articles/PMC5856312/ /pubmed/29544512 http://dx.doi.org/10.1186/s13014-018-0993-2 Text en © The Authors. 2018, corrected publication June 2018. Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sun, Wen-zhao
Zhang, Dan-dan
Peng, Ying-lin
Chen, li
Kang, De-hua
Wang, Bin
Deng, Xiao-wu
Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
title Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
title_full Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
title_fullStr Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
title_full_unstemmed Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
title_short Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
title_sort retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856312/
https://www.ncbi.nlm.nih.gov/pubmed/29544512
http://dx.doi.org/10.1186/s13014-018-0993-2
work_keys_str_mv AT sunwenzhao retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis
AT zhangdandan retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis
AT pengyinglin retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis
AT chenli retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis
AT kangdehua retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis
AT wangbin retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis
AT dengxiaowu retrospectivedosimetrystudyofintensitymodulatedradiationtherapyfornasopharyngealcarcinomameasurementguideddosereconstructionandanalysis